H2O Innovation Surpasses 50 Installations for its Clearlogx® & Digital Solutions
08 Abril 2019 - 9:00AM
(TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the
“Corporation”) is proud to announce that Clearlogx®, its
proprietary coagulant control technology, has recently won three
(3) new projects in the United States, totalling $498,000. The
Corporation now has its digital solutions installed on more than 50
sites.
This patented control technology, acquired by H2O Innovation, is
used in both conventional and membrane filtration (MF/UF) systems
to automatically adjust the feed of specialty coagulants based on a
specific control algorithm. By optimizing the coagulant dosage in
conventional or membrane treatment systems, this software can
improve the performance of the plant, reducing costly carryover
and/or membrane fouling, providing tremendous savings in chemical,
energy, and maintenance costs.
Over the last few months, H2O Innovation has completed
installation of three (3) new Clearlogx® projects: one (1) in
California and two (2) in North Carolina. The California contract
was a result of additional scope to an existing H2O Innovation
capital equipment project. This project also included the use of
Zeta potential for optimal control of particle charge. Clearlogx®
can also be installed on system built by other system suppliers, as
was the case for the two North Carolina contracts. For all three
projects, Clearlogx® was required to meet environmental
regulations, reduce organics & disinfection by-products and
minimize fouling of the membranes. All three of the systems
associated with these recent Clearlogx® projects were conventional
clarification followed by membrane filtration.
“We are hitting our stride with this technology, finding the
opportunities where it is a good fit in our market. With each of
these projects, we have been able to closely control chemical feed
to optimize the process, leading to more efficient operation and
less hassle for the operations staff. Clearlogx® projects also put
us in a good position to continue to support our customers through
the supply of our specialty coagulants and the use of our Intelogx™
data monitoring software”, stated Gregory Madden, Vice
President Aftermarket & Digital Solutions.
About Clearlogx®Clearlogx® is a
proprietary technology, which precisely and continuously controls
the feed of specialty coagulants used in water treatment to
maintain a proper pH level and an optimum particle charge, while
simultaneously improving overall treatment process efficiency. For
more information, please visit
www.h2oinnovation.com/services/digital-solutions/.
About H2O Innovation H2O
Innovation designs and provides state-of-the-art, custom-built and
integrated water treatment solutions based on membrane filtration
technology for municipal, industrial, energy and natural resources
end-users. The Corporation’s activities rely on three pillars which
are i) water and wastewater projects; ii) specialty products and
services, including a complete line of specialty chemicals,
consumables, specialized products for the water treatment industry
as well as control and monitoring systems; and iii) operation and
maintenance services for water and wastewater treatment systems.
For more information, visit www.h2oinnovation.com.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) nor the Alternext Exchange accepts
responsibility for the adequacy or accuracy of this release.
Source: H2O Innovation Inc.
www.h2oinnovation.com Contact: Marc
Blanchet+1 418-688-0170 marc.blanchet@h2oinnovation.com
H2O Innovation (EU:ALHEO)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
H2O Innovation (EU:ALHEO)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024